Boehringer Ingelheim Director, Patient Engagement in RIDGEFIELD, Connecticut

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities.


The Director, Patient Engagement, US Office of Patient Affairs, has primary responsibility for driving patient engagement (PE) strategies and facilitating PE activities to advance the Company's commitment to improving patients’ lives. S/he actively works to advance the understanding of PE and optimize its deployment across the business, developing innovative approaches and best practices and education to reinforce the value of the patient perspective, experience and insights in advancing BI's work in drug development, programming and decision-making.

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees

Duties & Responsibilities:

  • PE Strategy, Facilitation and Implementation

  • In partnership with the Head, US Office of Patient Affairs (OPA), helps set the PE strategy aligned to BI strategic priorities and business objectives; helps ensure effective implementation of the PE strategy across the Company

  • Advances overall understanding, expertise and capabilities in PE methodology to grow and advance the PE function within BI and optimizes PE practices across the business; leads PE Ambassador Network

  • Implements the PE strategy and ensures implementation across BI; ensures early adoption of PE in the drug development process by identifying and encouraging Patient Advocacy and Professional Relations (PAR) collaborations with research, development and clinical operations; ensures evolution of PE strategy and process as appropriate to meet needs of the business and drug development process

  • Collaborates with other members of the PAR team to provide guidance, tools and support to help enable their role as facilitators of PE across BI

  • PE Best Practice Sharing and Measurement

  • Defines, standardizes and communicates best practices that showcase the value of PE, including BI examples and industry-wide cases and trends; elevates company-wide awareness and understanding of PE, patient-focused drug development and patient-centered legislation by educating and inspiring internal stakeholders

  • Attends external meetings to identify and cultivate opportunities including speaking engagements for both themselves and senior leaders, including through connections with similarly formed teams across the industry; shares PE best practices

  • Partners with the Head of OPA to develop and track Key Performance Indicators (KPIs) and measurable outcomes for PE with a focus on measuring the cost and value of engaging patients and Patient Advocacy Groups (PAGs) in key activities across the span of the product lifecycle

  • Financial Management

  • Oversees PE budget for the Head of OPA, including monitoring expenditures and revising spending, as needed. Provides periodic reports and analyses to leadership and team members, as needed


  • Bachelor's degree from an accredited institution required and Master's from an accredited institution preferred

  • PE training and/or certification a plus.

  • Five (5) to eight plus (8+) years in communications, pharmaceuticals and/or patient engagement; three (3) to five plus (5+) years in patient engagement preferred

  • Experience in the following areas is preferred: patient engagement, patient-centricity, professional stakeholder relations, public relations, government relations, marketing, drug development, clinical trials, philanthropy

  • Strong understanding of patient-focused drug development, patient-centered and patient experience trials and best practice knowledge in pharma/advocacy group venture philanthropy partnerships

  • Proven understanding of key trends in both internal and external environment that impact PE, specifically in areas that affect BI's work across clinical development programs

  • Solid understanding through experience of patient and consumer trends as it relates to new forms of patient/consumer interactions: e-business, social media, patient online communities, trial simulations and patient registries

  • Strong analytical skills; strong listening skills and an ability to maintain composure at all times

  • Ability to work well under pressure, prioritize competing projects and effectively problem solve

  • Proven understanding of the needs and behaviors of people living with or at risk for various diseases or conditions of greatest interest to the Company as well as pressing public health issues, including but not limited to patients, their families, consumers

  • Proven ability to build and maintain partnerships with key external stakeholders

  • Proven ability to build, maintain and influence effective working relationships with key internal and external stakeholders, including marketing, medical affairs, public relations

  • Sensitivity to diverse groups of people both internal and external with the ability to show response for many different opinions and perspectives, including tolerance for ambiguity

  • Ability to work with minimal supervision and be an effective team player

  • Sound judgment in decision making

  • Requires consummate patient advocacy professional with extensive experience building and executing PE strategies and activities with additional appreciation and insight into EE, PC and stakeholder/partner engagement.

  • Thorough understanding of PE principles and regulatory policies related to patient focused drug development.

Eligibility Requirements:

  • Must be legally authorized to work in the United States without restriction.

  • Must be willing to take a drug test and post-offer physical (if required)

  • Must be 18 years of age or older

Our Culture:

Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighborhoods where we live and work. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.



Organization: US-BI Pharma/BI USA

Title: Director, Patient Engagement

Location: Americas-United States-CT-Ridgefield

Requisition ID: 185780